Recent Proton Experience?

Posted by docwatson @docwatson, Aug 31, 2025

Six years ago I was treated with proton at Mayo PHX 😁. Age 68, Gleason 7, PSA 11 (now 0.2 😁😁). I am part of a support group that offers our experiences, however I’m afraid mine is now dated. I got 43 treatments, I understand standard is now 25. Back then they used balloons 🤪, I understand now they don’t but the water/bladder prep is tricky. Everyone’s case is different, but can someone provide a recent (last year or so) experience with the current protocol? Thanks in advance!

Interested in more discussions like this? Go to the Prostate Cancer Support Group.

Profile picture for gently @gently

jeffmarc, no. It's an old long before Space Oar. It really is a water balloon that they insert and fill before each radiation fraction. It isn't a surgical placement.
Rectal balloons are still in use, though.

Jump to this post

@gently
@gently, your original and second post was and is correct.

The balloons were being used before Space/Oar was available. And it is still being done today as you posted.

Many patients for medical reason cannot have the Space/Oar done. Or they chose not to have it done. This is not a personal opinion. I asked my UFHPTI R/O about it after I saw the balloon technique being set up after me and he said the above to me. So it comes from a UFHPTI medical professional R/O.

I know when I finished my treatments at UFHPTI the next patient (who must have been same individual after me) the techs were setting up the balloon insert. It did not look bad at all but takes longer for set you up for your treatments.

REPLY
Profile picture for brianjarvis @brianjarvis

When I had proton radiation treatments in April 2021, my RO had never used SpaceOAR; he had only used endorectal balloons. (So, I connected him with Boston Scientific to get the product in.) I was his first.

SpaceOAR Hydrogel was FDA-approved in 2015; an improved version (SpaceOAR Vue) was FDA-approved in 2019. Barrigel was FDA-approved in 2022. BioProtect was FDA-approved in 2023.

Clinical data showed that SpaceOAR offered improved benefits when compared to the older endorectal balloons: https://www.urologytimes.com/view/hydrogel-spacer-lowers-rectal-bleeding-vs-balloon-immobilization-treatment

Jump to this post

Brian… very interesting history, I hadn’t heard that! When I was treated in 2019, one of the nurses heard that I had the spaceOAR, balloons, 43 treatments, and Lupron (45mg, 6mos) she commented “oh, you’re getting the gold treatment!”. I don’t know if she was referring to a Cadillac or gilding 😉, but I was glad I took the conservative route as I would prefer not to do this again! Thanks again for your comments and best wishes.

REPLY

...is the proton technique on third party pay? Is longer lasting Space Oar [Vue] now the preferred method along with fluid filling of bladder before each session?

REPLY

I just finish proton RT in May and because of the location of my tumor a gel spacer could not be used, so I had the balloon. Although certainly not terrible, it was the most uncomfortable part of the whole treatment. I was talking to the technicians one day and asked about balloons and they said probably 50% of their patients used them. I was surprised as I thought gels were more common now.

REPLY
Profile picture for brianjarvis @brianjarvis

When I had proton radiation treatments in April 2021, my RO had never used SpaceOAR; he had only used endorectal balloons. (So, I connected him with Boston Scientific to get the product in.) I was his first.

SpaceOAR Hydrogel was FDA-approved in 2015; an improved version (SpaceOAR Vue) was FDA-approved in 2019. Barrigel was FDA-approved in 2022. BioProtect was FDA-approved in 2023.

Clinical data showed that SpaceOAR offered improved benefits when compared to the older endorectal balloons: https://www.urologytimes.com/view/hydrogel-spacer-lowers-rectal-bleeding-vs-balloon-immobilization-treatment

Jump to this post

The balloon actually makes no sense to me: it inflates the diameter of the rectum, swelling the walls outward and closer to the beams.
So maybe the inner epithelium might get spared - depending on the direction of the beam, but I would think the outer tissue would be more vulnerable. The Gel Spacer is at least between the gland and the rectum - that kind of barrier makes sense.
Yes, proton advocates like to say that their technology is more precise, but there are plenty of SE’s reported in the literature ( though possibly less).

REPLY
Profile picture for thmssllvn @thmssllvn

...is the proton technique on third party pay? Is longer lasting Space Oar [Vue] now the preferred method along with fluid filling of bladder before each session?

Jump to this post

Medicare paid for my proton radiation treatments in 2021.

SpaceOAR Vue is a modification of the original SpaceOAR Hydrogel; it contains approximately 1% iodine bound to the hydrogel to be more visible under CT scan.

Studies show that SpaceOAR not only reduces rectal radiation dose, but also from late GI and GU toxicities, and provides urinary, bowel, and sexual quality-of-life improvement: https://pubmed.ncbi.nlm.nih.gov/34029607/

REPLY
Profile picture for daveinflorida @daveinflorida

I just finish proton RT in May and because of the location of my tumor a gel spacer could not be used, so I had the balloon. Although certainly not terrible, it was the most uncomfortable part of the whole treatment. I was talking to the technicians one day and asked about balloons and they said probably 50% of their patients used them. I was surprised as I thought gels were more common now.

Jump to this post

These days, if there’s concern “… of the location of the tumor” such that “a gel spacer could not be used…”, the goto is BioProtect. (FDA-approved in 2023.)

As this paper states, “…if you're worried about microscopic extracapsular extension being displaced through the liquid of the spacer,…..the likelihood of spreading extracapsular cells is virtually nil.”
> https://www.urotoday.com/video-lectures/lugpa-2024/video/3006-symmetry-visibility-and-control-the-advantages-of-the-bioprotect-balloon-in-prostate-cancer-treatment-edward-soffen.html

REPLY
Profile picture for gently @gently

Water is a very effective radiation shield. Protons and photons lose energy when passing through water. It's a rectal balloon that move the rectum further away from the radiation field and stabilizes it positionally.

Jump to this post

The advantage of SpaceOAR (and Barrigel) over the endorectal balloons is that the balloon protects most of the rectum from the radiation.

However, with balloons the anterior portion of the rectum is still fully within the field of radiation. By injecting the rectal spacer gel into the perirectal space, an additional 1.0-1.3cm of space is added between the entire rectum and the radiation.

REPLY
Profile picture for heavyphil @heavyphil

The balloon actually makes no sense to me: it inflates the diameter of the rectum, swelling the walls outward and closer to the beams.
So maybe the inner epithelium might get spared - depending on the direction of the beam, but I would think the outer tissue would be more vulnerable. The Gel Spacer is at least between the gland and the rectum - that kind of barrier makes sense.
Yes, proton advocates like to say that their technology is more precise, but there are plenty of SE’s reported in the literature ( though possibly less).

Jump to this post

The endorectal balloon made sense in its day, (“You go to war with the army you have, not the army you wish you had.”) It was the best they had 10+ years ago.

With FDA-approval of SpaceOAR in 2015 (and Barrigel in 2022, and BioProtect in 2023), you’d think that they all would’ve migrated to one of the other spacers by now.

But, even with prostate biopsies, some centers are still doing transrectal biopsies, even though transperineal biopsies are clearly superior.

It takes years to get a good idea into medicine; it takes twice as long to get an old idea out of medicine……

REPLY
Profile picture for brianjarvis @brianjarvis

These days, if there’s concern “… of the location of the tumor” such that “a gel spacer could not be used…”, the goto is BioProtect. (FDA-approved in 2023.)

As this paper states, “…if you're worried about microscopic extracapsular extension being displaced through the liquid of the spacer,…..the likelihood of spreading extracapsular cells is virtually nil.”
> https://www.urotoday.com/video-lectures/lugpa-2024/video/3006-symmetry-visibility-and-control-the-advantages-of-the-bioprotect-balloon-in-prostate-cancer-treatment-edward-soffen.html

Jump to this post

Well, it’s done now but I guess my RO isn’t up on the research. And that was the problem, a small ECE, although I don’t know if it was microscopic. But I think it was also the actual location of the tumor also.

REPLY
Please sign in or register to post a reply.